Table 2.
Test subjects | Antioxidant methods | Mechanism | References |
---|---|---|---|
ECV304 cell line | Increases antioxidant GSH | Increases the expression of gamma-glutamylcysteine synthetase | [161] |
Brain homogenates from rats | Suppresses pro-oxidant enzymes | Reduces the activity of pro-oxidant enzymes such as XO and MPO | [162] |
Cells from mice | Anti-inflammatory | Exerts anti-inflammatory effect via the ERK/Nrf2/HO-1 signaling | [163] |
Oocytes from mice | Increases antioxidant enzyme | Increase the expression of GPx1/SOD1 | [164] |
Mice | Increases antioxidant enzyme | Enhances the SIRT3 activity; increases the binding affinity of FoxO3a to the promoters of both SOD2 and CAT | [165] |
Mice | Increases antioxidant enzyme | Increases in total antioxidative capacity and SOD level via MT1/AMPK pathway | [166] |
Rats | Maintenance of mitochondrial homeostasis | Increases the activity of the respiratory chain complexes I and IV; reduces electron leakage and ROS generation | [167] |
Abbreviations: ECV304 cell line, human umbilical vascular endothelial cell line; GSH, glutathione; XO, xanthine oxidase; MPO, myeloperoxidase; ERK, extracellular regulated kinase; Nrf2, nuclear factor erythroid 2-related factor 2; HO-1, heme oxygenase-1; GPx1, glutathione peroxidase 1; SOD, superoxide dismutase; FoxO3a, forkhead box O 3a; CAT, catalase; MT1, melatonin membrane receptor 1; AMPK, AMP-dependent protein kinase; ROS, reactive oxygen species.